The company has increased its dividend by 33% since 2022 and currently pays annually.
CVS Health Corporation (CVS) currently holds a consensus from Wall Street analysts, with 20 out of 24 experts recommending it as a top pick as of late April 2026. Trading near $78.38 , the stock is widely considered an attractive value play due to its low valuation relative to its $400+ billion annual revenue and robust cash flow. Key Investment Highlights should i buy cvs stock
Management projects 2026 adjusted EPS between . The company has increased its dividend by 33%
: The company is still managing significant debt from past major acquisitions, such as Aetna. Summary of Analyst Sentiment (April 2026) Percentage Strong Buy Buy Hold/Sell should i buy cvs stock